HIGHLIGHTS
- who: Dan Wang from the Department of General Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany have published the article: Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis, in the Journal: (JOURNAL)
- what: The aim of this study was to analyze the benefits of only surgery neoadjuvant radiotherapy adjuvant radiotherapy and surgery plus chemotherapy for OS in patients with non-metastatic PDAC. Pancreatic Ductal Adenocarcinoma (PDAC) is a highly malignant tumor with a 5-year survival of about 7% and is on pace to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.